VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,086 | -99.7% | 282,268 | +520.3% | 0.12% | +310.7% |
| Q4 2019 | $747,000 | +20.7% | 45,507 | -2.4% | 0.03% | +7.7% |
| Q3 2019 | $619,000 | -5.9% | 46,623 | -0.2% | 0.03% | 0.0% |
| Q2 2019 | $658,000 | -23.8% | 46,733 | -0.3% | 0.03% | -25.7% |
| Q1 2019 | $863,000 | -64.9% | 46,877 | -53.3% | 0.04% | -31.4% |
| Q4 2018 | $2,461,000 | +113.6% | 100,279 | +99.8% | 0.05% | +15.9% |
| Q3 2018 | $1,152,000 | +20.4% | 50,182 | -0.2% | 0.04% | +12.8% |
| Q2 2018 | $957,000 | +6.1% | 50,260 | -6.1% | 0.04% | +2.6% |
| Q1 2018 | $902,000 | -23.1% | 53,530 | -30.6% | 0.04% | -22.4% |
| Q4 2017 | $1,173,000 | -52.7% | 77,160 | -44.3% | 0.05% | -50.5% |
| Q3 2017 | $2,478,000 | – | 138,446 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |